Bioanalysis of recombinant proteins and antibodies by mass spectrometry
文献情報
Eric Ezan, Mathieu Dubois, François Becher
In recent years, biotechnologically-derived drugs have been a major focus of research and development in the pharmaceutical industry. Their pharmacokinetics and pharmacokinetic/pharmacodynamic relationships impact every stage of the development process and require their assessment in the circulation in preclinical species and in humans. To this end, immunoassays are a reference, but standardisation remains an issue owing to the restricted pattern of antibody specificity and interference with endogenous components. As an alternative, we report here analytical strategies involving liquid chromatography coupled to mass spectrometry (LC-MS) for the accurate quantification of therapeutic proteins and antibodies in biological fluids.
関連文献
IF 6.222
Contents listIF 6.222
Synthesis and hydrogen evolving catalysis of a panchromatic photochemical molecular deviceIF 6.367
Contents listIF 6.222
An elemental S/P photocatalyst for hydrogen evolution from water under visible to near-infrared light irradiationIF 6.222
Redox responsive Pluronic micelle mediated delivery of functional siRNA: a modular nano-assembly for targeted deliveryIF 6.843
Synthesis of aviation fuel from bio-derived isophoroneIF 6.367
CaMoO4 nanosheet arrays for efficient and durable water oxidation electrocatalysis under alkaline conditionsIF 6.222
Life cycle assessment of power-to-gas with biogas as the carbon sourceIF 6.367
Strong circularly polarized luminescence of an octahedral chromium(iii) complexIF 6.222
掲載誌
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.